As of June 2024 AtriCure has a market cap of $1.09 Billion. This makes AtriCure the world's 5042th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.09 B | -35.53% |
2023 | $1.69 B | -18.05% |
2022 | $2.06 B | -35.37% |
2021 | $3.19 B | 27.42% |
2020 | $2.50 B | 94.42% |
2019 | $1.28 B | 9.13% |
2018 | $1.18 B | 87.86% |
2017 | $0.62 B | -3.34% |
2016 | $0.65 B | -10.18% |
2015 | $0.72 B | 31.56% |
2014 | $0.55 B | 26.76% |
2013 | $0.43 B | 272.5% |
2012 | $0.11 B | -35.36% |
2011 | $0.18 B | 12.11% |
2010 | $0.16 B | 73.47% |
2009 | $92.73 M | 192.63% |
2008 | $31.69 M | -82.9% |
2007 | $0.18 B | 74.13% |
2006 | $0.10 B | -16.06% |
2005 | $0.12 B |
On May 31st, 2024 the market cap of AtriCure was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.98 B | 32,268.25% | ๐บ๐ธ USA |
Medtronic MDT | $106.70 B | 9,684.51% | ๐ฎ๐ช Ireland |
Abiomed ABMD | $17.18 B | 1,475.43% | ๐บ๐ธ USA |
Boston Scientific BSX | $111.10 B | 10,087.78% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $52.35 B | 4,701.30% | ๐บ๐ธ USA |
Teleflex TFX | $9.84 B | 803.02% | ๐บ๐ธ USA |
Cooper Companies COO | $18.74 B | 1,618.85% | ๐บ๐ธ USA |